Fetzima and Stools - watery - a phase IV clinical study of FDA data

Summary:

Stools - watery is reported as a side effect among people who take Fetzima (levomilnacipran hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Vitamin B12, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Stools - watery when taking Fetzima. It is created by eHealthMe based on reports of 2,014 people who have side effects when taking Fetzima from the FDA, and is updated regularly.

What is Fetzima?

Fetzima has active ingredients of levomilnacipran hydrochloride. It is often used in depression. eHealthMe is studying from 2,077 Fetzima users. Check the latest studies of Fetzima.

What is Stools - watery?

Stools - watery is found to be associated with 4,671 drugs and 5,940 conditions by eHealthMe. Check the latest studies of Stools - watery.

On Jul, 13, 2026

2,014 people reported to have side effects when taking Fetzima.
Among them, 57 people (2.83%) have Stools - watery.

Among these 57 people:

How long have people been on Fetzima when they have Stools - watery? *

What is the gender of people who have Stools - watery when taking Fetzima? *

female: 82.46 %
male: 17.54 %

What is the age of people who have Stools - watery when taking Fetzima? *

What are other drugs people take besides Fetzima? *

What are other side effects people have besides Stools - watery? *

Nausea (feeling of having an urge to vomit): 16 people, 28.07%
Dizziness: 14 people, 24.56%
Headache (pain in head): 14 people, 24.56%
Nausea And Vomiting: 14 people, 24.56%
Fatigue (feeling of tiredness): 11 people, 19.30%
Drug Ineffective: 9 people, 15.79%
High Blood Pressure: 8 people, 14.04%
Constipation: 8 people, 14.04%
Insomnia (sleeplessness): 7 people, 12.28%
Abdominal Pain: 7 people, 12.28%

What are the existing conditions these people have? *

Stress And Anxiety: 11 people, 19.30%
High Blood Pressure: 10 people, 17.54%
Pain: 8 people, 14.04%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 8.77%
Headache (pain in head): 5 people, 8.77%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 7.02%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 4 people, 7.02%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 3 people, 5.26%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.26%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Fetzima and have Stools - watery?

- Check whether Stools - watery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fetzima:

Fetzima (2,077 reports)

Stools - watery treatments and more:

Stools - watery (756,290 reports)

Browse all side effects of Fetzima:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stools - watery:

Stools - watery (4,671 drugs)

Browse all the conditions that are associated with Stools - watery:

Stools - watery (5,940 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levomilnacipran hydrochloride (the active ingredients of Fetzima) and Fetzima (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.